Optical coherence tomography guided in-stent thrombus removal in patients with acute coronary syndromes

Alessandro Di Giorgio1, Davide Capodanno, Vito Ramazzotti

  • 1Interventional Cardiology, San Giovanni Hospital, Via dell'Amba Aradam, 8, 00184 Rome, Italy.

Insights

Optical coherence tomography (OCT) guided intervention effectively reduces in-stent thrombus in acute coronary syndrome (ACS) patients after percutaneous coronary intervention (PCI). This OCT-guided strategy is safe and feasible for improving stent lumen area and reducing thrombus burden.

Area of Science:

  • Cardiovascular Interventions
  • Medical Imaging
  • Interventional Cardiology

Background:

  • Thrombus persistence within stent struts is common in acute coronary syndromes (ACS) post-percutaneous coronary intervention (PCI).
  • This residual thrombus may increase the risk of stent thrombosis.
  • Optimal angiographic results do not always guarantee complete thrombus resolution.

Purpose of the Study:

  • To quantify in-stent thrombus using optical coherence tomography (OCT) after optimal angiographic results in ACS patients undergoing PCI.
  • To evaluate the feasibility and safety of an OCT-guided strategy for in-stent thrombus removal.

Main Methods:

  • Eighty ACS patients undergoing PCI were randomized into angio-guided PCI and OCT-guided PCI groups.
  • The OCT-guided group received additional OCT-driven in-stent balloon dilatation to reduce thrombus.
  • In-stent thrombus area and lumen dimensions were assessed using OCT.

Main Results:

  • Overall in-stent thrombus area was 4.3%, with maximal encroachment of 16.7%.
  • OCT-guided intervention significantly increased stented and lumen areas (p=0.002 and p<0.001, respectively).
  • This strategy significantly reduced in-stent thrombus area in absolute and relative terms (p=0.001 for both).

Conclusions:

  • OCT-guided in-stent balloon dilatations are feasible and safe.
  • This approach effectively reduces in-stent thrombus burden in ACS patients.
  • The strategy may improve outcomes for patients undergoing PCI for ACS.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...